Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mini-MENDS
NCT04801589Phase 3Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in delirium, sponsored by Vanderbilt University Medical Center. Started May 2021; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT04801589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801589.